Seraph Biosciences
Detroit
About Seraph Biosciences
Seraph Biosciences is a biomedical device company developing real-time pathogen detection systems used to treat infections. By leveraging the principles of Raman Spectroscopy, Seraspec represents a paradigm shift away from current methods for screening and identification of dangerous bacterial, viral, and fungal pathogens. Its product serves as a real-time handheld pathogen detection and identification device that enable health care providers to optimize clinical decision making in a globally integrated society.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.2M
- Last round: Series Unknown (Jan 2020)
- Website: seraspec.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/seraph-biosciences-143849 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.